{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:30:15Z","timestamp":1794562215449,"version":"4.9.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ajo.2026.05.021","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:45:30Z","timestamp":1779291930000},"page":"54-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Incidence and Progression of Glaucoma Following Boston Type 1 Keratoprosthesis: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"289","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9241-6428","authenticated-orcid":false,"given":"Abdelrahman","family":"Abu Osba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korolos","family":"Sawires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Bondok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Abdelaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Harissi-Dagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Betsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 S.","family":"Pollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2026.05.021_bib0001","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/ICO.0000000000004005","article-title":"Keratoprosthesis indications, outcomes, and future directions","volume":"45","author":"Razavi","year":"2026","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.021_bib0002","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/ICU.0000000000000373","article-title":"The Boston keratoprosthesis","volume":"28","author":"Saeed","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.021_bib0003","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/ICU.0b013e3283477d0d","article-title":"Expanding indications for the boston keratoprosthesis","volume":"22","author":"Colby","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2026.05.021_bib0004","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2147\/OPTH.S219270","article-title":"Boston type 1 keratoprosthesis: updated perspectives","volume":"14","author":"Nonpassopon","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"11","key":"10.1016\/j.ajo.2026.05.021_bib0005","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.ophtha.2014.05.030","article-title":"Long-term outcomes of Boston type 1 keratoprosthesis implantation: a retrospective multicenter cohort","volume":"121","author":"Srikumaran","year":"2014","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.ajo.2026.05.021_bib0006","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ophtha.2015.03.025","article-title":"Boston keratoprosthesis: outcomes and complications: a report by the American Academy of Ophthalmology","volume":"122","author":"Lee","year":"2015","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1016\/j.ajo.2026.05.021_bib0007","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1097\/ICO.0000000000002641","article-title":"Endophthalmitis in eyes with the Boston type I keratoprosthesis: incidence, recurrence, risk factors, and outcomes","volume":"40","author":"Bostan","year":"2021","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.021_bib0008","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1001\/archopht.119.4.484","article-title":"Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and Risk Factors","volume":"119","author":"Nouri","year":"2001","journal-title":"Arch Ophthalmol."},{"issue":"2","key":"10.1016\/j.ajo.2026.05.021_bib0009","first-page":"72","article-title":"Protection of the ocular surface after keratoprosthesis surgery: the role of soft contact lenses","volume":"28","author":"Dohlman","year":"2002","journal-title":"CLAO J."},{"issue":"2","key":"10.1016\/j.ajo.2026.05.021_bib0010","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajo.2011.07.022","article-title":"Prevalence, progression, and impact of glaucoma on vision after boston type 1 keratoprosthesis surgery","volume":"153","author":"Talajic","year":"2012","journal-title":"Am J Ophthalmol."},{"issue":"4","key":"10.1016\/j.ajo.2026.05.021_bib0011","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ophtha.2008.12.058","article-title":"The Boston type i keratoprosthesis: improving outcomes and expanding indications","volume":"116","author":"Aldave","year":"2009","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2026.05.021_bib0012","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/ICO.0b013e3181a186dc","article-title":"Boston keratoprosthesis outcomes and complications","volume":"28","author":"Chew","year":"2009","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.021_bib0013","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/ICO.0000000000000067","article-title":"Glaucoma progression and role of glaucoma surgery in patients with boston keratoprosthesis","volume":"33","author":"Crnej","year":"2014","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.021_bib0014","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/ICU.0b013e328343723d","article-title":"Evaluation and management of glaucoma after keratoprosthesis","volume":"22","author":"Banitt","year":"2011","journal-title":"Curr Opin Ophthalmol."},{"issue":"12","key":"10.1016\/j.ajo.2026.05.021_bib0015","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1097\/ICO.0b013e31821eead6","article-title":"Glaucoma in Eyes with Severe Chemical Burn, before and after Keratoprosthesis","volume":"30","author":"Cade","year":"2011","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2026.05.021_bib0016","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ajo.2007.11.002","article-title":"The Boston keratoprosthesis in Stevens-Johnson syndrome","volume":"145","author":"Sayegh","year":"2008","journal-title":"Am J Ophthalmol."},{"issue":"2","key":"10.1016\/j.ajo.2026.05.021_bib0017","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/ICU.0000000000000924","article-title":"Glaucoma management in patients with penetrating keratoplasty or keratoprosthesis","volume":"34","author":"Sun","year":"2023","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.ajo.2026.05.021_bib0018","first-page":"n7","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.ajo.2026.05.021_bib0019","doi-asserted-by":"crossref","first-page":"478","DOI":"10.11124\/JBIES-22-00125","article-title":"Revising the JBI quantitative Critical Appraisal Tools to Improve Their Applicability: an Overview of Methods and the Development Process","volume":"21","author":"Barker","year":"2023","journal-title":"JBI Evid Synth"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.021_bib0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","article-title":"GRADE Guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ajo.2026.05.021_sbref0021","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (updated August 2024)","year":"2024"},{"key":"10.1016\/j.ajo.2026.05.021_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9648614","article-title":"Risk of endophthalmitis in Boston type 1 keratoprosthesis combined with vitrectomy and silicone oil insertion","volume":"2019","author":"Abou Shousha","year":"2019","journal-title":"J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.021_bib0023","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ajo.2014.12.024","article-title":"Predictors of visual outcomes following boston type 1 keratoprosthesis implantation","volume":"159","author":"Ahmad","year":"2015","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2026.05.021_bib0024","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.ophtha.2012.02.015","article-title":"International results with the Boston type I keratoprosthesis","volume":"119","author":"Aldave","year":"2012","journal-title":"Ophthalmology"},{"issue":"8","key":"10.1016\/j.ajo.2026.05.021_bib0025","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/ICO.0000000000002962","article-title":"Intermediate-term visual outcomes and complications of type 1 Boston keratoprosthesis with and without glaucoma surgery","volume":"41","author":"AlHilali","year":"2022","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2026.05.021_bib0026","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajo.2019.03.016","article-title":"The Aurolab Keratoprosthesis (KPro) versus the Boston type I Kpro: 5-year clinical outcomes in 134 cases of bilateral corneal blindness","volume":"205","author":"Basu","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2026.05.021_bib0027","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/ICO.0000000000000164","article-title":"Boston Keratoprosthesis type 1 for herpes simplex and herpes zoster keratopathy","volume":"33","author":"Brown","year":"2014","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.021_bib0028","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1097\/SCS.0000000000006164","article-title":"Comparison of the clinical efficacy of Boston keratoprosthesis type I and repetitive penetrating keratoplasty for refractory keratopathy","volume":"31","author":"Chen","year":"2020","journal-title":"J Craniofac Surg"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.021_bib0029","first-page":"869","article-title":"Post-operative outcomes associated with Boston type 1 keratoprosthesis implantation in Northeast China","volume":"17","author":"Gao","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ajo.2026.05.021_bib0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ajo.2021.01.006","article-title":"Glaucoma risk factors and outcomes following Boston keratoprosthesis type 1 surgery","volume":"226","author":"Geoffrion","year":"2021","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.021_bib0031","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40123-021-00446-y","article-title":"Clinical experience in patients with ocular burns treated with Boston type I keratoprosthesis implantation with or without prophylactic Ahmed Glaucoma valve implantation","volume":"11","author":"Gu","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"22","key":"10.1016\/j.ajo.2026.05.021_bib0032","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.3390\/jcm13226710","article-title":"Clinical outcomes and early postoperative complications in Boston type I keratoprosthesis implantation: a retrospective study","volume":"13","author":"Krysik","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.021_bib0033","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ophtha.2016.08.003","article-title":"Safety of concurrent Boston type I keratoprosthesis and glaucoma drainage device implantation","volume":"124","author":"Lenis","year":"2017","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.021_bib0034","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1097\/IAE.0000000000002036","article-title":"Comparison of visual and anatomical outcomes of eyes undergoing type I Boston keratoprosthesis with combination pars plana vitrectomy with eyes without combination vitrectomy","volume":"38","author":"Lim","year":"2018","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2026.05.021_bib0035","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ajo.2019.06.018","article-title":"Glaucoma management in patients with aniridia and Boston type 1 keratoprosthesis","volume":"207","author":"Nascimento","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2026.05.021_bib0036","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ajo.2024.08.035","article-title":"Results of Lucia keratoprosthesis implantation in severe corneal disease","volume":"268","author":"Ortiz-Morales","year":"2024","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2026.05.021_bib0037","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/IJG.0b013e318259b2fc","article-title":"Angle closure after Boston keratoprosthesis","volume":"22","author":"Panarelli","year":"2013","journal-title":"J Glaucoma"},{"issue":"9","key":"10.1016\/j.ajo.2026.05.021_bib0038","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/ICO.0000000000000204","article-title":"Boston type 1 keratoprosthesis for chemical and thermal injury","volume":"33","author":"Phillips","year":"2014","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.ajo.2026.05.021_bib0039","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1038\/s41433-022-02299-6","article-title":"Incidence and risk factors for glaucoma development and progression after corneal transplantation","volume":"37","author":"Saini","year":"2023","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.1016\/j.ajo.2026.05.021_bib0040","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41433-018-0016-4","article-title":"Boston keratoprosthesis type 1: outcomes of the first 38 cases performed at moorfields eye hospital","volume":"32","author":"Samarawickrama","year":"2018","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.021_bib0041","first-page":"137","article-title":"Management of glaucoma with Boston type 1 keratoprosthesis","volume":"86","author":"Utine","year":"2023","journal-title":"Arq Bras Oftalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.021_bib0042","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3390\/jcm13040975","article-title":"Outcomes of Boston keratoprosthesis type I implantation in Poland: a retrospective study on 118 patients","volume":"13","author":"Wr\u00f3blewska-Czajka","year":"2024","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.ajo.2026.05.021_bib0043","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/ICO.0000000000002986","article-title":"Glaucoma evaluation and management in eyes with Boston type 1 and aurolab keratoprostheses in an Indian cohort","volume":"41","author":"Senthil","year":"2022","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.ajo.2026.05.021_bib0044","first-page":"1601","article-title":"Long-term visual outcomes of the Boston type I keratoprosthesis in Canada","volume":"104","author":"Szigiato","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.021_bib0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ophtha.2014.08.007","article-title":"Anterior Segment Optical Coherence tomography in the long-term follow-up and detection of glaucoma in Boston type i keratoprosthesis","volume":"122","author":"Qian","year":"2015","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.021_bib0046","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.survophthal.2017.09.003","article-title":"Glaucoma after corneal replacement","volume":"63","author":"Baltaziak","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.ajo.2026.05.021_bib0047","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/OPTH.S349719","article-title":"Challenges of glaucoma management in patients with type I Boston keratoprosthesis","volume":"16","author":"AlHilali","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2026.05.021_bib0048","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1167\/iovs.62.4.20","article-title":"Tear film cytokine profile of patients with the Boston keratoprosthesis type 1: comparing patients with and without glaucoma","volume":"62","author":"Geoffrion","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2026.05.021_bib0049","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/IJG.0b013e3181a2fbeb","article-title":"Shunts to divert aqueous humor to distant epithelialized cavities after keratoprosthesis surgery","volume":"19","author":"Dohlman","year":"2010","journal-title":"J Glaucoma"},{"key":"10.1016\/j.ajo.2026.05.021_bib0050","article-title":"Retroprosthetic membrane is associated with subsequent development of De novo angle closure in eyes with Boston keratoprosthesis","author":"Karas","year":"2025","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2026.05.021_bib0051","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ajo.2021.09.005","article-title":"Assessment of the role and timing of glaucoma surgery in Boston keratoprosthesis type 1 patients","volume":"235","author":"Geoffrion","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2026.05.021_bib0052","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1097\/IJG.0b013e31829e55f8","article-title":"Outcomes of pars plana glaucoma drainage implant in Boston Type 1 keratoprosthesis surgery","volume":"23","author":"Huh","year":"2014","journal-title":"J Glaucoma"},{"issue":"8","key":"10.1016\/j.ajo.2026.05.021_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182190","article-title":"Vision retention in early versus delayed glaucoma surgical intervention in patients with Boston keratoprosthesis type 1","volume":"12","author":"Lin","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ajo.2026.05.021_bib0054","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/ICO.0000000000002800","article-title":"Reliability of several glaucoma tests in patients with Boston type 1 keratoprosthesis","volume":"41","author":"Akpek","year":"2022","journal-title":"Cornea"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426002552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939426002552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:17:47Z","timestamp":1794561467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939426002552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":54,"alternative-id":["S0002939426002552"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2026.05.021","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Progression of Glaucoma Following Boston Type 1 Keratoprosthesis: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2026.05.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}